Disorders

The Center for Bleeding and Clotting Disorders provides a complete range of care for children and adolescents with bleeding and thrombotic (clotting) disorders. Children's Minnesota belongs to a nationwide network of federally funded Hemophilia Treatment Centers (HTCs) and is the only such program in the region focused solely on pediatrics. This designation ensures that children and adolescents receive comprehensive care from a team of pediatric experts in bleeding and clotting disorders.

Comprehensive Clinics - Many of our programs offer specialty clinics that include a variety of experts available in a single clinic visit.

Patient and Family Education Materials If you need quick, clear info about a kids' health topic, we have it all!

If your child is diagnosed with cancer or a blood disorder, we understand it's not easy news to hear, but know that Children's Minnesota will be with you and your child along every step of the way. We believe that by providing the best journey for the patient and family, it will lead to the best outcomes. You'll receive first-rate, compassionate care from the moment we meet.

The cancer and blood disorders team at Children's Minnesota has the training, knowledge and technology to treat a wide range of conditions. Nearly 900 children are admitted annually as inpatients to the Jim and Colleen Ryan Pediatric Cancer and Blood Disorders Center at Children's Minnesota in Minneapolis, making us the largest program in the upper midwest. And while we're known as a leader and innovator in the field of pediatric cancer and blood disorder treatment, we never forget that each patient is someone's child. Compassion always factors into our approach. We are on the journey with you, because we believe that better journeys lead to better outcomes.

It can be frightening to hear that a child has cancer or a blood disorder. At Children's Minnesota, we're experts in treating the disease and supporting the patient and family. In addition to offering advanced, individualized care for newly diagnosed children, teens and young adults up to age 26 with cancers and blood disorders, we also provide innovative treatment for rare, relapsed and recurrent cancers.